share_log

Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Doctorglasses Chain Co.,Ltd. 's(深交所代碼:300622)基本面看起來相當強勁:市場對這隻股票的看法會錯嗎?
Simply Wall St ·  2023/10/19 08:54

Doctorglasses ChainLtd (SZSE:300622) has had a rough three months with its share price down 16%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. In this article, we decided to focus on Doctorglasses ChainLtd's ROE.

醫生眼鏡連鎖有限公司(SZSE:300622)經歷了艱難的三個月,其股價下跌了16%。但如果你仔細觀察,你可能會猜到,它強勁的財務狀況可能意味著,考慮到市場通常會獎勵財務狀況良好的公司,該股可能會在長期內增值。在這篇文章中,我們決定把重點放在Doctorgles ChainLtd的ROE上。

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.

股本回報率(ROE)是對一家公司增值和管理投資者資金的效率的測試。換句話說,這是一個衡量公司股東提供的資本回報率的盈利比率。

View our latest analysis for Doctorglasses ChainLtd

查看我們對DoctorGlass ChainLtd.的最新分析

How Do You Calculate Return On Equity?

你如何計算股本回報率?

The formula for return on equity is:

這個股本回報率公式是:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

股本回報率=(持續經營的)淨利潤?股東權益

So, based on the above formula, the ROE for Doctorglasses ChainLtd is:

因此,根據上述公式,醫生眼鏡連鎖有限公司的淨資產收益率為:

17% = CN¥123m ÷ CN¥741m (Based on the trailing twelve months to June 2023).

17%=1.23億元×7.41億元(以截至2023年6月的12個月為基礎)。

The 'return' is the yearly profit. That means that for every CN¥1 worth of shareholders' equity, the company generated CN¥0.17 in profit.

“回報”就是年度利潤。這意味著,每增加價值1元的股東權益,公司就會產生0.17元的利潤。

Why Is ROE Important For Earnings Growth?

為什麼淨資產收益率對收益增長很重要?

We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.

我們已經證實,淨資產收益率是一家公司未來收益的有效盈利指標。我們現在需要評估公司將多少利潤再投資或“保留”用於未來的增長,這就讓我們對公司的增長潛力有了一個瞭解。一般來說,在其他條件相同的情況下,股本回報率和利潤留存較高的公司比不具備這些特徵的公司有更高的增長率。

A Side By Side comparison of Doctorglasses ChainLtd's Earnings Growth And 17% ROE

DoctorGlass ChainLtd.盈利增長與17%淨資產收益率的並列比較

To start with, Doctorglasses ChainLtd's ROE looks acceptable. Further, the company's ROE compares quite favorably to the industry average of 11%. This certainly adds some context to Doctorglasses ChainLtd's decent 14% net income growth seen over the past five years.

首先,Doctorgles ChainLtd的淨資產收益率看起來可以接受。此外,該公司的淨資產收益率(ROE)與行業平均水準11%相比相當有利。這無疑為Doctorgles ChainLtd在過去五年中實現了14%的可觀淨收入增長增添了一些背景。

Next, on comparing Doctorglasses ChainLtd's net income growth with the industry, we found that the company's reported growth is similar to the industry average growth rate of 17% over the last few years.

接下來,將Doctorgles ChainLtd的淨收入增長與行業進行比較,我們發現該公司報告的增長與過去幾年17%的行業平均增長率相似。

past-earnings-growth
SZSE:300622 Past Earnings Growth October 19th 2023
深圳證交所:過去300622的收益增長2023年10月19日

Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about Doctorglasses ChainLtd's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.

盈利增長是評估一隻股票時需要考慮的一個重要指標。投資者應該嘗試確定預期的收益增長或下降是否已計入價格,無論是哪種情況。通過這樣做,他們將知道股票是將進入清澈的藍色水域,還是等待沼澤水域。如果你想知道Doctorgles Chain Ltd的估值,看看這個衡量其本益比的指標,與其行業相比。

Is Doctorglasses ChainLtd Using Its Retained Earnings Effectively?

DoctorGlass ChainLtd是否有效地利用了其留存收益?

The high three-year median payout ratio of 76% (or a retention ratio of 24%) for Doctorglasses ChainLtd suggests that the company's growth wasn't really hampered despite it returning most of its income to its shareholders.

Doctorgles ChainLtd的三年派息率中值為76%(或留存率為24%),這表明儘管該公司將大部分收入返還給股東,但該公司的增長並未受到真正的阻礙。

Moreover, Doctorglasses ChainLtd is determined to keep sharing its profits with shareholders which we infer from its long history of six years of paying a dividend.

此外,Doctorgles ChainLtd決心繼續與股東分享利潤,這是我們從其支付股息的悠久歷史中推斷出來的。

Conclusion

結論

On the whole, we feel that Doctorglasses ChainLtd's performance has been quite good. In particular, its high ROE is quite noteworthy and also the probable explanation behind its considerable earnings growth. Yet, the company is retaining a small portion of its profits. Which means that the company has been able to grow its earnings in spite of it, so that's not too bad. With that said, the latest industry analyst forecasts reveal that the company's earnings are expected to accelerate. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.

總體而言,我們覺得醫生眼鏡連鎖有限公司的表現相當不錯。特別是,其高淨資產收益率相當值得注意,也是其可觀收益增長背後的可能解釋。然而,該公司保留了一小部分利潤。這意味著,儘管如此,該公司仍能實現收益增長,所以這並不是太糟糕。儘管如此,最新的行業分析師預測顯示,該公司的收益預計將加速增長。要了解更多有關該公司未來收益增長預測的資訊,請查看以下內容免費報告分析師對該公司的預測,以瞭解更多資訊.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論